253605-31-1 Usage
Description
N-(TERT-BUTYL)HYDROXYLAMINE ACETATE 97, also known as NtBuHA acetate, is a derivative of hydroxylamine that exhibits thioesterase-mimetic and antioxidant properties. It has been studied for its effects on cathepsin D activity and may be utilized in the preparation of various compounds, such as (Z)-α-5-bromo-N-tert-butyl-2-methoxyphenylnitrone and ONO-type pincer ligand hydroxyphenyl nitrones.
Uses
Used in Pharmaceutical Research:
N-(TERT-BUTYL)HYDROXYLAMINE ACETATE 97 is used as a research compound for studying its effects on cathepsin D activity, which is an important enzyme involved in various biological processes, including protein degradation and apoptosis.
Used in Chemical Synthesis:
N-(TERT-BUTYL)HYDROXYLAMINE ACETATE 97 is used as a starting material or intermediate in the synthesis of various organic compounds, such as (Z)-α-5-bromo-N-tert-butyl-2-methoxyphenylnitrone and ONO-type pincer ligand hydroxyphenyl nitrones. These compounds have potential applications in various fields, including pharmaceuticals, materials science, and catalysis.
Used in Antioxidant Applications:
Due to its antioxidant characteristics, N-(TERT-BUTYL)HYDROXYLAMINE ACETATE 97 may be used in the development of antioxidants for various industries, such as food, cosmetics, and pharmaceuticals, to protect against oxidative damage and extend the shelf life of products.
Check Digit Verification of cas no
The CAS Registry Mumber 253605-31-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,6,0 and 5 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 253605-31:
(8*2)+(7*5)+(6*3)+(5*6)+(4*0)+(3*5)+(2*3)+(1*1)=121
121 % 10 = 1
So 253605-31-1 is a valid CAS Registry Number.
InChI:InChI=1/C4H11NO.C2H4O2/c1-4(2,3)5-6;1-2(3)4/h5-6H,1-3H3;1H3,(H,3,4)
253605-31-1Relevant articles and documents
Salts of N-tert-butylhydroxylamine
-
, (2008/06/13)
Novel salts of N-tert-butylhydroxylamine with lower carboxylic acids are disclosed, together with processes for their preparation. The salts possess advantageous properties that render them useful in synthesis.
